Arkadios Wealth Advisors Galapagos Nv Transaction History

Arkadios Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$47.03 - $57.12 $1,363 - $1,656	-29 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$52.17 - $70.2 $10,016 - $13,478	-192 Reduced 86.88%	29 $1,000
Q2 2021 Jul 28, 2021	BUY	$68.86 - $83.34 $7,161 - $8,667	104 Added 88.89%	221 $15,000
Q1 2021 Apr 26, 2021	BUY	$76.15 - $111.94 $7,462 - $10,970	98 Added 515.79%	117 $9,000
Q4 2020 Feb 09, 2021	BUY	$96.85 - $148.25 $1,840 - $2,816	19 New	19 $1,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.